Skip Navigation



ToxSci Advance Access published online on March 31, 2004

Toxicological Sciences, doi:10.1093/toxsci/kfh132
Toxicological Sciences © Society of Toxicology 2004; all rights reserved
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
79/2/248    most recent
kfh132v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Trouba, K. J.
Right arrow Articles by Germolec, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trouba, K. J.
Right arrow Articles by Germolec, D. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received January 7, 2004; accepted March 15, 2004
© 2004 Toxicological Sciences © Society of Toxicology 2004; all rights reserved.

Environmental Toxicology

Micromolar Concentrations of Sodium Arsenite Induce Cyclooxygenase-2 Expression and Stimulate p42/44 Mitogen-Activated Protein Kinase Phosphorylation in Normal Human Epidermal Keratinocytes

K. J. Trouba 1 and D. R. Germolec 1*

1 Laboratory of Molecular Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, 27709, USA

* To whom correspondence should be addressed. E-mail: germolec{at}niehs.nih.gov.


   Abstract

Based on evidence that arsenic modulates pro-inflammatory events that are involved in skin carcinogenecity, it was hypothesized that in normal human epidermal keratinocytes (NHEK) arsenic: 1) increases expression of the procarcinogenic enzyme cyclooxygenase-2 (COX-2); and 2) this occurs via specific mitogen and stress signaling pathways. To test this hypothesis, NHEK were exposed to sodium arsenite and COX-2 expression, prostaglandin E2 (PGE2) secretion, mitogen-activated protein kinase (MAPK) phosphorylation, and DNA synthesis were quantified. Inhibitors of p42/44 and p38 MAPKs were used to evaluate the contribution of mitogen and stress signaling to the modulation of COX-2. Our results demonstrate that arsenite (0.005-5 µM) elevates COX-2 expression, PGE2 secretion (2.5-5 µM), and DNA synthesis (1-5 µM). Arsenite stimulated p42/44 but not p38 MAPK phosphorylation (2.5 µM), responses different than those produced by epidermal growth factor. Inhibition of mitogen-activated protein kinase kinase (MAPKK) and p38 MAPK using PD98059 (20 µM) and SB202190 (5 µM), respectively, attenuated the elevation of COX-2 protein induced by arsenite whereas physiological concentrations of three COX-2 inhibitors (e.g., NS-398, piroxicam, and aspirin) reduced arsenite-stimulated DNA synthesis. These data indicate that arsenite elevates COX-2 in NHEK at the transcriptional and translational level as well as increases PGE2 secretion. Compounds that inhibit COX-2 expression and activity may be useful in the scientific study, prevention, and treatment of arsenic skin carcinogenesis, and deserve further investigation.

Key Words: cyclooxygenase, arsenic, PD98059, SB202190, MAP kinase .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
C.-Y. Chai, Y.-C. Huang, W.-C. Hung, W.-Y. Kang, and W.-T. Chen
Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells
Mutagenesis, November 1, 2007; 22(6): 403 - 408.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
K. E. Eblin, T. G. Bredfeldt, S. Buffington, and A. J. Gandolfi
Mitogenic Signal Transduction Caused by Monomethylarsonous Acid in Human Bladder Cells: Role in Arsenic-Induced Carcinogenesis
Toxicol. Sci., February 1, 2007; 95(2): 321 - 330.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.